|
1
|
Ngan HY, Bender H, Benedet JL, Jones H,
Montruccoli GC and Pecorelli S: FIGO Committee on Gynecologic
Oncology: Gestational trophoblastic neoplasia, FIGO 2000 staging
and classification. Int J Gynaecol Obstet. 83(Suppl 1): S175–S177.
2003. View Article : Google Scholar
|
|
2
|
Matsui H, Suzuka K, Iitsuka Y, Seki K and
Sekiya S: Combination chemotherapy with methotrexate, etoposide,
and actinomycin D for high-risk gestational trophoblastic tumors.
Gynecol Oncol. 78:28–31. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bower M, Newlands ES, Holden L, Short D,
Brock C, Rustin GJ, Begent RH and Bagshawe KD: EMA/CO for high-risk
gestational trophoblastic tumors: Results from a cohort of 272
patients. J Clin Oncol. 15:2636–2643. 1997.PubMed/NCBI
|
|
4
|
Newlands ES, Mulholland PJ, Holden L,
Seckl MJ and Rustin GJ: Etoposide and cisplatin/etoposide,
methotrexate, and actinomycin D (EMA) chemotherapy for patients
with high-risk gestational trophoblastic tumors refractory to
EMA/cyclophosphamide and vincristine chemotherapy and patients
presenting with metastatic placental site trophoblastic tumors. J
Clin Oncol. 18:854–859. 2000.PubMed/NCBI
|
|
5
|
Matsui H, Suzuka K, Iitsuka Y, Yamazawa K,
Tanaka N, Mitsuhashi A, Seki K and Sekiya S: Salvage combination
chemotherapy with 5-fluorouracil and actinomycin D for patients
with refractory, high-risk gestational trophoblastic tumors.
Cancer. 95:1051–1054. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang J, Short D, Sebire NJ, Lindsay I,
Newlands ES, Schmid P, Savage PM and Seckl MJ: Salvage chemotherapy
of relapsed or high-risk gestational trophoblastic neoplasia (GTN)
with paclitaxel/cisplatin alternating with paclitaxel/etoposide
(TP/TE). Ann Oncol. 19:1578–1583. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
van Besien K, Verschraegen C, Mehra R,
Giralt S, Kudelka AP, Edwards CL, Piamsonboom S, Termrungruanglert
W, Champlin R and Kavanagh JJ: Complete remission of refractory
gestational trophoblastic disease with brain metastases treated
with multicycle ifosfamide, carboplatin, and etoposide (ICE) and
stem cell rescue. Gynecol Oncol. 65:366–369. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lotz JP, André T, Donsimoni R, Firmin C,
Bouleuc C, Bonnak H, Merad Z, Esteso A, Gerota J and Izrael V: High
dose chemotherapy with ifosfamide, carboplatin, and etoposide
combined with autologous bone marrow transplantation for the
treatment of poor-prognosis germ cell tumors and metastatic
trophoblastic disease in adults. Cancer. 75:874–885. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fields KK, Zorsky PE, Hiemenz JW, Kronish
LE and Elfenbein GJ: Ifosfamide, carboplatin, and etoposide: A new
regimen with a broad spectrum of activity. J Clin Oncol.
12:544–552. 1994.PubMed/NCBI
|
|
10
|
Collins RH Jr, White CS, Stringer CA and
Fay JW: Successful treatment of refractory gestational
trophoblastic neoplasm with high-dose etoposide and
cyclophosphamide. Gynecol Oncol. 43:317–319. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lotz JP, Machover D, Malassagne B, Hingh
B, Donsimoni R, Gumus Y, Gerota J, Lam Y, Tulliez M, Marsiglia H,
et al: Phase I–II study of two consecutive courses of high-dose
epipodophyllotoxin, ifosfamide, and carboplatin with autologous
bone marrow transplantation for treatment of adult patients with
solid tumors. J Clin Oncol. 9:1860–1870. 1991.PubMed/NCBI
|
|
12
|
Giacalone PL, Benos P, Donnadio D and
Laffargue F: High-dose chemotherapy with autologous bone marrow
transplantation for refractory metastatic gestational trophoblastic
disease. Gynecol Oncol. 58:383–385. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Aoki Y, Kodama S, Kurata H, Kase H and
Tanaka K: Failure of high-dose chemotherapy with peripheral blood
stem cell support for refractory placental site trophoblastic
tumor. Gynecol Obstet Invest. 47:214–216. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rinne K, Shahabi S and Cole L: Following
metastatic placental site trophoblastic tumor with urine beta-core
fragment. Gynecol Oncol. 74:302–303. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Knox S, Brooks SE, Wong-You-Cheong J,
Ioffe O, Meisenberg B and Goldstein DP: Choriocarcinoma and
epithelial trophoblastic tumor: Successful treatment of relapse
with hysterectomy and high-dose chemotherapy with peripheral stem
cell support: A case report. Gynecol Oncol. 85:204–208. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Markman M: Experience with platinum-based
and high-dose chemotherapy in patients with gestational
trophoblastic disease: Possible implications for future management.
J Cancer Res Clin Oncol. 130:383–387. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
El-Helw LM, Seckl MJ, Haynes R, Evans LS,
Lorigan PC, Long J, Kanfer EJ, Newlands ES and Hancock BW:
High-dose chemotherapy and peripheral blood stem cell support in
refractory gestational trophoblastic neoplasia. Br J Cancer.
93:620–621. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Benigno BB: High-dose chemotherapy with
autologous stem cell support as salvage therapy in recurrent
gestational trophoblastic disease. Int J Gynecol Cancer.
23:1331–1333. 2013. View Article : Google Scholar : PubMed/NCBI
|
